4 completed, 1 terminated, 1 unknown. 6 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Completed 4, Terminated 1, Unknown 1 |
Follow Bacterial Infection: new trials by email Literature Review of Bacterial Infection trials Research Report on Bacterial Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Oral Preparation on Bacterial Colonization of the Pharyngeal Mucosa in Surgery of Head and Neck Cancer Chlorhexidine, NaCl 0.9 % - Bacterial Infection | Phase 3 | Completed | Rennes University Hospital | 80 | 2016-05-23 | 2018-12-20 |
| Chlorhexidine Gluconate Cleansing in Preventing Central Line Associated Bloodstream Infection and Acquisition of Multi-drug Resistant Organisms in Younger Patients With Cancer or Undergoing Donor Stem Cell Transplant Chlorhexidine Gluconate Skin Cleanser, Laboratory Biomarker Analysis, Mild Soap Skin Cleanser - Bacterial Infection, Benign Neoplasm | Phase 3 | Completed | Children's Oncology Group | 177 | 2013-11-04 | 2021-06-22 |
| Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation levofloxacin - Acute Leukemias of Ambiguous Lineage, Bacterial Infection | Phase 3 | Completed | Children's Oncology Group | 624 | 2011-09-01 | 2020-12-07 |
| Comparative Antibiotic Therapy for Subjects With Pulmonary Infiltrates in the ICU Meropenem, Standard antibiotic therapy - Bacterial Infection | Phase 3 | Terminated | National Institute of Allergy and Infectious Diseases (NIAID) | 460 | 2006-10-01 | 2013-06-07 |
| Efficacy Study of Community-Based Treatment of Serious Bacterial Infections in Young Infants ceftriaxone, procaine penicillin and gentamicin, oral cotrimoxazole and gentamicin - Bacterial Infection, Sepsis | Phase 3 | Unknown | Aga Khan University | 426 | 2003-11-01 | 2006-09-11 |
| Phase III Randomized Study of the Inhalation of Tobramycin in Patients With Cystic Fibrosis tobramycin - Cystic Fibrosis, Bacterial Infection | Phase 3 | Completed | FDA Office of Orphan Products Development | 200 | 1995-06-01 | 2015-03-25 |
Bacterial Infections (6) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (2) · Communicable Diseases (1) · Cystic Fibrosis (1) · Diarrhea (1) · Genetic Diseases, Inborn (1) · Head and Neck Neoplasms (1) · Immune System Diseases (1) · Leukemia, Biphenotypic, Acute (1) · Mycoses (1) · Neonatal Sepsis (1) · Neoplasms (1) · Neutropenia (1) · Rare Diseases (1) · Respiratory Tract Diseases (1)
Bacterial Infections and Mycoses (6) · Infections (6) · Pathological Conditions, Signs and Symptoms (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Immune System Diseases (2) · Immunoproliferative Disorders (2) · Infant, Newborn, Diseases (2) · Leukemia (2) · Leukemia, Lymphoid (2) · Lymphatic Diseases (2) · Lymphoproliferative Disorders (2) · Neoplasms (2) · Neoplasms by Histologic Type (2)
Ceftriaxone (1) · Chlorhexidine (1) · Gentamicins (1) · Levofloxacin (1) · Meropenem (1) · Penicillin G Procaine (1) · Tobramycin (1) · Trimethoprim, Sulfamethoxazole Drug Combination (1) · chlorhexidine gluconate (1)
Children's Oncology Group (2) · Aga Khan University (1) · FDA Office of Orphan Products Development (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · Rennes University Hospital (1)
United States (3) · Canada (2) · France (1) · Pakistan (1) · Puerto Rico (1)
Alan Bruce Montgomery (1) · Anita KM Zaidi, MBBS, SM (1) · Danielle M Zerr (1) · Sarah Alexander, MD (1)
U10CA095861 (2), R01CA163394 (1), UG1CA189955 (1)